Edition:
India

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

117.00USD
18 Nov 2019
Change (% chg)

-- (--)
Prev Close
$117.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,887
52-wk High
$119.00
52-wk Low
$71.22

Latest Key Developments (Source: Significant Developments)

China Biologic Announces Receipt Of Preliminary Non-Binding "Going Private" Proposal
Thursday, 19 Sep 2019 

Sept 18 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC ANNOUNCES RECEIPT OF PRELIMINARY NON-BINDING "GOING PRIVATE" PROPOSAL.CHINA BIOLOGIC PRODUCTS HOLDINGS - RECEIVED PRELIMINARY NON-BINDING PROPOSAL LETTER FROM BEACHHEAD HOLDINGS LIMITED, CITIC CAPITAL CHINA PARTNERS IV.CHINA BIOLOGIC PRODUCTS - BEACHHEAD, OTHERS PROPOSING TO BUY CO FOR $120/SHARE IN CASH IN A "GOING PRIVATE" TRANSACTION.CHINA BIOLOGIC PRODUCTS - RECEIVED NON-BINDING PROPOSAL LETTER FROM PARTIES INCLUDING PW MEDTECH GROUP LIMITED, PARFIELD INTERNATIONAL.CHINA BIOLOGIC PRODUCTS - GOT NON-BINDING PROPOSAL LETTER FROM PARTIES INCLUDING HH SUM-XXII HOLDINGS LIMITED AND V-SCIENCES INVESTMENTS.  Full Article

China Biologic Reports Q2 2019
Tuesday, 6 Aug 2019 

Aug 5 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2019.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.24.Q2 EARNINGS PER SHARE $1.06.QTRLY TOTAL SALES $135.7 MILLION VERSUS $120.4 MILLION.APPOINTED JOSEPH CHOW AS CEO OF COMPANY, EFFECTIVE AUGUST 5, 2019.CHOW WILL CONTINUE TO SERVE AS A DIRECTOR AND CHAIRMAN OF COMPANY.REITERATES ITS FORECAST FOR FULL YEAR 2019.  Full Article

China Biologic Products Says Unit Enters Agreement With Fujian Pingtan & Xinyu Yongshuo
Saturday, 29 Jun 2019 

June 28 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC PRODUCTS - UNIT ENTERED AGREEMENT WITH FUJIAN PINGTAN CENTURIUM INVESTMENT PARTNERSHIP & XINYU YONGSHUO MANAGEMENT AND CONSULTING.CHINA BIOLOGIC PRODUCTS - UNIT TO BUY FUJIAN PINGTAN'S 15% & XINYU YONGSHUO'S 5%, OF EQUITY INTEREST IN TIANXINFU (BEIJING) MEDICAL APPLIANCE FOR RMB820 MILLION.CHINA BIOLOGIC PRODUCTS - UPON COMPLETION OF TRANSACTION, EXPECTED TO OCCUR IN Q3 2019, TIANXINFU WILL BECOME INDIRECT WHOLLY-OWNED SUBSIDIARY OF CO.  Full Article

China Biologic Reports Q1 Adjusted Non-GAAP Earnings Per Share $1.11
Saturday, 11 May 2019 

May 10 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2019.Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.11.Q1 EARNINGS PER SHARE $0.94.Q1 EARNINGS PER SHARE ESTIMATE $1.00 -- REFINITIV IBES DATA.CHINA BIOLOGIC PRODUCTS - Q1 TOTAL SALES INCREASED BY 15.4% TO $129.8 MILLION.REITERATES ITS FORECAST FOR FULL YEAR 2019.CHINA BIOLOGIC PRODUCTS - IN MAY, BOARD AUTHORIZED NEW SHARE REPURCHASE PROGRAM UNDER WHICH CO MAY REPURCHASE UP TO $150 MILLION OF SHARES OVER NEXT 12 MONTHS.  Full Article

China Biologic Reports Financial Results For The Fourth Quarter And Fiscal Year 2018
Thursday, 7 Mar 2019 

March 6 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2018.Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.76.Q4 EARNINGS PER SHARE $0.87.BOARD OF DIRECTORS EXTENDS PREVIOUSLY APPROVED SHARE REPURCHASE PROGRAM.QTRLY TOTAL SALES $114.9 MILLION VERSUS $90.1 MILLION.CHINA BIOLOGIC PRODUCTS HOLDINGS - BOARD APPROVED EXTENSION TO PREVIOUSLY AUTHORIZED $100 MILLION SHARE REPURCHASE PROGRAM FOR ANOTHER 6 MONTHS UNTIL OCT 31, 2019.CHINA BIOLOGIC PRODUCTS HOLDINGS SEES 2019 NON-GAAP ADJUSTED INCOME FROM OPERATING AND NON-GAAP ADJUSTED NET INCOME TO INCREASE BY 4%-6% IN RMB TERMS OVER FY 2018 RESULTS.CHINA BIOLOGIC PRODUCTS HOLDINGS - TOTAL SALES, NON-GAAP ADJUSTED NET INCOME IN USD TERMS IN 2019 COULD BE AFFECTED BY FOREIGN CURRENCY TRANSLATION IMPACT.FY2019 EARNINGS PER SHARE VIEW $4.38, REVENUE VIEW $479.9 MILLION -- REFINITIV IBES DATA."ANTICIPATE THAT POLICY HEADWINDS WILL CONTINUE TO BE CHALLENGING IN SHORT TERM".  Full Article

China Biologic Products Holdings says On Feb 3, Board Elected Joseph Chow To Be New Chairman Of Board
Monday, 4 Feb 2019 

Feb 4 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC PRODUCTS HOLDINGS- ON FEB 1, 2019, ZHIJUN TONG INFORMED CO THAT HE WAS RESIGNING FROM HIS POSITIONS AS PRESIDENT AND DIRECTOR OF CO.CHINA BIOLOGIC PRODUCTS HOLDINGS- ON FEB 1, 2019, ZHIJUN TONG INFORMED CO THAT HE WAS RESIGNING FROM HIS POSITIONS AS PRESIDENT AND DIRECTOR OF CO .CHINA BIOLOGIC PRODUCTS HOLDINGS- ON FEB 3, BOARD UNANIMOUSLY ELECTED JOSEPH CHOW TO BE NEW CHAIRMAN OF BOARD IN SUCCESSION TO DAVID HUI LI.CHINA BIOLOGIC PRODUCTS HOLDINGS- DAVID HUI LI CONTINUES TO SERVE AS A DIRECTOR ON THE BOARD - SEC FILING.  Full Article

China Biologic Reiterates Full Year 2018 Financial Forecast
Monday, 7 Jan 2019 

Jan 7 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REITERATES FULL YEAR 2018 FINANCIAL FORECAST.  Full Article

China Biologic Announces Dismissal Of Lawsuit Filed In Cayman Islands By Former Chairman
Friday, 14 Dec 2018 

Dec 14 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC ANNOUNCES DISMISSAL OF LAWSUIT FILED IN CAYMAN ISLANDS BY FORMER CHAIRMAN.CHINA BIOLOGIC PRODUCTS - GRAND COURT OF CAYMAN ISLANDS DISMISSED LAWSUIT PREVIOUSLY FILED AGAINST CO BY FORMER CHAIRMAN, CEO DAVID (XIAOYING) GAO.  Full Article

David Gao Confirms Lawsuit Against China Biologic Products
Wednesday, 29 Aug 2018 

Aug 29 (Reuters) - David Gao :DAVID GAO CONFIRMS LAWSUIT AGAINST CHINA BIOLOGIC PRODUCTS TO PROTECT SHAREHOLDERS’ BEST INTERESTS.DAVID GAO - CONFIRMED FILED LAWSUIT AGAINST CO RELATED TO PRIVATE PLACEMENT OF SHARES TO SELECT INVESTOR GROUP.  Full Article

China Biologic Responds To Lawsuit Filed In Cayman Islands By Former Chairman
Wednesday, 29 Aug 2018 

Aug 28 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC RESPONDS TO LAWSUIT FILED IN CAYMAN ISLANDS BY FORMER CHAIRMAN.CHINA BIOLOGIC PRODUCTS HOLDINGS - ISSUED STATEMENT IN RESPONSE TO LAWSUIT FILED AGAINST COMPANY IN CAYMAN ISLANDS BY DAVID (XIAOYING) GAO.CHINA BIOLOGIC PRODUCTS HOLDINGS INC - CLOSED 3.8 MILLION SHARES IN PRIVATE PLACEMENT & WILL CLOSE REMAINING IN ACCORDANCE WITH TRANSACTION AGREEMENTS.  Full Article

UPDATE 1-China Biologic receives offer to be taken private at $120 a share

Sept 18 China Biologic Products Holdings Inc said on Wednesday it had received an offer from a consortium of buyers that will pay $1.93 billion in cash to buy shares that they do not already own to take the company private.